Price
No data yet.
Social Signal Score
Analyst Ratings
17 analystsRevenue
$71.55M+636.52%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Chad Robins
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 624
- Beta
- 2.10
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 3.38
Financials
Revenue
$71.55M+636.5%Net Income
$-39.79MEBITDA
$-12.07MFree Cash Flow
$-7.58MEPS (diluted)
$-0.25Shares Outstanding (diluted)
157.70M+48.9%Operating Expenses
$66.73MCash & Debt
$344.25MReturn of Capital
$25.00MRevenue by Segment (annual)
$154.34MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $276.98M | $-59.50M | $-0.39 |
| 2024 | $178.96M | $-159.49M | $-1.08 |
| 2023 | $170.28M | $-225.25M | $-1.56 |
| 2022 | $185.31M | $-200.19M | $-1.00 |
| 2021 | $154.34M | $-207.28M | $-1.46 |
| 2020 | $98.38M | $-146.23M | $-1.06 |
| 2019 | $85.07M | $-68.61M | $-0.47 |
| 2018 | $55.66M | $-46.45M | $-0.44 |
| 2017 | $38.45M | $-42.83M | $-0.41 |
Valuation
ADPThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
98-2.50%Social Signal Score
Mentions (9)
- News (RSS)zerohedge·1d ago·Neutral
California Attorney General Subpoenas OpenAI In Cybersecurity Inquiry California Attorney General Subpoenas OpenAI In Cybersecurity Inquiry Authored by Kimberly Hayek via The Epoch Times, California Attorney General Rob Bonta served an investigative subpoena to OpenAI on Wednesday, according to a statement released Thursday. The OpenAI logo on May 20, 2024. Dado Ruvic/Illustration/ReutersThe demand is part of the California Department of Justice's ongoing investigation into incidents arising fro
View source ↗ - Newsfeeds.newsfilecorp.com·7d ago·Negative
Adaptogenics Health Corp. Announces Closing of Over Subscribed Non-Brokered Private Placement Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to
View source ↗ - Newsglobenewswire.com·11d ago·Neutral
…nsitive MRD Testing in New International Myeloma Society Definition of Cure SEATTLE, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today highlighted the new consensus definition of cure for multiple myeloma, presented at the International Myeloma Society (IMS) 23rd Annual Meeting in Glasgow, Scot…
View source ↗ - News (RSS)investing·11d ago·Neutral
Adaptive Biotechnologies stock hits 52-week high at 28.79 USD
View source ↗ - News (RSS)yahoo·13d ago·Neutral
Adaptive Biotechnologies (ADPT): Can Blood Cancer Guidelines Boost Repeat Testing?
View source ↗ - Newsbusinesswire.com·14d ago·Negative
QAD | Redzone Expands ChampionAI Across Adaptive ERP with Champion Assist and New Accounts Payable Champion CHICAGO & MIAMI--(BUSINESS WIRE)--Champions of Manufacturing — QAD | Redzone, the company behind the world's number one platform for manufacturers, announced a major expansion of ChampionAI, the agentic AI engine that runs the entire QAD | Redzone platform: Champion Assist, a conversational interface inside Adaptive ERP, and the new Accounts Payable Champion, an AI agent that manages the i
View source ↗ - News (RSS)seekingalpha·20d ago·Positive
Adaptive Biotechnologies Corporation (ADPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsseekingalpha.com·20d ago·Positive
Adaptive Biotechnologies Corporation (ADPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Adaptive Biotechnologies Corporation (ADPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsgeekwire.com·49d ago·Neutral
Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science Harlan Robins spent years as the co-founder and chief scientific officer of Adaptive Biotechnologies, helping build massive datasets to decode
View source ↗
Earnings
Wed, Nov 4(in 4 weeks)
Consensus estimate $-0.10 per share
Typical surprise +29.2% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$-0.25 vs $-0.13miss
- Tue, May 5$-0.13 vs $-0.16beat
- Thu, Feb 5$-0.09 vs $-0.19beat
- Thu, Nov 6$0.06 vs $-0.18beat
- Tue, Aug 5$-0.17 vs $-0.24beat
- Mon, May 5$-0.20 vs $-0.34beat
Estimates and results for ADPT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ADPT officers and directors.
- Bought
- —
- Sold
- $54.2m
0 trades
36 trades
- Lo Francissold
- Lo Francissold
- Bobulsky Susansold
- Owen Katey Einterzsold
- Hershberg Robertsold
- Hershberg Robertsold
- Robins Chad Msold
- Robins Chad Msold
64 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Mar 8, 2022 (22d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.